Top Markets
Coin of the day
Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.

NLTX
Hisse Senetlerindeki Sıralama #26682
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused... Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington.
Hisse Fiyatı
$3.49
Son senkronizasyon: 2023-12-19
Piyasa Değeri
$38.68M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Neoleukin Therapeutics, Inc. (NLTX)

Kategori

Neoleukin Therapeutics, Inc. (NLTX) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $3.45 - 2023-12-01

Gün sonu en düşük fiyat: $64.26 - 2014-03-01
Neoleukin Therapeutics, Inc. için hisse fiyatı geçmişi: 2014 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2023 54.08%
2022 -91.29%
2021 -59.35%
2020 43.82%
2019 289.17%
2018 -79.56%
2017 -28.51%
2016 28.68%
2015 63.39%
2014 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$171.67 -
DE
$163.33 25.54%
DE
$38.00 22.72%
JP
$220.12 32.96%
CH
$21.01 11.96%
IN